We invite you to join us for the Minnesota Sarcoma Research Conference 2022: Progress and Promise, a hybrid event sponsored by Rein in Sarcoma (RIS). Register here This year, you can attend virtually or in-person at the University of Minnesota Twin Cities campus. Some sessions may be recorded and will be available on YouTube after…
The Seam Podcast Rein in Sarcomas supporter, Dr. Brittany L. Siontis, was recently interviewed by The Seam to discuss sarcoma and advances in research. Dr Siontis currently serves as the Principal Investigator of several active clinical trials at Mayo Clinic through the Sarcoma Medical Oncology Group. This was a great opportunity to raise awareness of…
Rein in Sarcoma and Masonic Cancer Center, University of Minnesota are excited to sponsor the 2022 Minnesota Sarcoma Research Conference: Progress and Promise. The symposium will feature talks from leaders in sarcoma research and a poster session with sarcoma research projects from graduate students. The event will be a forum for researchers to share findings with…
Back in 2004 when Rein in Sarcoma awarded its first $10,000 research grant, it felt like a giant step along an uncharted path. Looking back, it now seems the initial $10,000 ‘seed’ has grown into a tall, broad, bright sunflower. That first grant funded research overseen by Logan Spector, Ph.D., director of the Division of Epidemiology and Clinical Research at the…
Rein in Sarcoma has awarded $40,000 in new sarcoma research grants to Children’s Minnesota and the Mayo Clinic. The grants were announced during the recent virtual Fall Fundraiser. The RIS Research Committee reviews the top proposals brought forward by each institution’s evaluation committee, and recommends final awards to the RIS Board of Directors for approval. …
Sarcoma survivor and Rein in Sarcoma volunteer, Miranda Mead, has served for the past three years as a Peer Reviewer for the United States Department of Cancer Peer Review Panel. Miranda works with leading researchers, scientists, and oncologists from around the country to determine which cancer research proposals they fund. This year, Miranda was asked…
KJT Group is conducting a study and looking for PEComa patients to share their experiences.
Rein in Sarcoma reached $2 million in sarcoma cancer research funding with its recent award of $150,000 for three University of Minnesota research projects. We celebrate this milestone in the organization’s 20th year of providing research funds to the UMN, Mayo Clinic, Children’s Minnesota, and SARC. We thank our donors for their generous and continued…
Rein in Sarcoma’s Board approved a research grant to the 2021 University of Minnesota at its January meeting. The number of grants were reduced based on buget decisions made in the spring of 2020. The University solicited requests for funding proposal from their researchers, blindly ranked them according to national standards, and recommended the proposal…
Sarcoma survivor and RIS volunteer Charlie Gerk recently participated in the evaluation of research applications submitted to the Peer Reviewed Cancer Research Program (PRCRP) of the Congressionally Directed Medical Research Programs (CDMRP). Charlie was nominated for participation in the program by Rein in Sarcoma. As a consumer reviewer, he was a full voting member, (along…
